Attila is an accomplished leader with over 20 years of experience in the global pharmaceutical and biotechnology industry. Prior to joining Triple Hair, Attila held various senior leadership positions within XCO Tech, Stelvio Therapeutics, Sirona Biochem, GlaxoSmithKline and Astellas Pharma, mainly in business development, sales, marketing, finance and medical affairs. As a business development expert, he has played leading roles in facilitating new business opportunities by developing and executing successful corporate strategies which have enabled successful licensing of pipeline assets to pharmaceutical partners worldwide. He was instrumental in 9 different innovative product launches into markets with large unmet needs, which have transformed the treatment landscape by delivering medicines of value to the patients that need them. Attila received an MBA from Queen’s University and an M.Sc. in Biochemistry from the University of Western Ontario.
We are thrilled that Attila has agreed to join our ranks to help deliver Triple Hair’s leading-edge products into the global pharmaceutical market. Attila has a solid reputation for building relationships of trust with external partners worldwide. More precisely, he will provide our team with his vast knowledge and experience in big pharma sales, marketing and licensing, and brings a solid understanding of biochemistry and keen ability to recognize the value of early stage products.
Having a skilled leader in business development with a proven track record is paramount for Triple Hair and we are very confident that Attila will help us succeed in meeting our objectives.
We will be presenting in Moncton on Tuesday, February 25 at 5:00 p.m. to investors interested in participating in the current round of financing. During the presentation, we will discuss Triple Hair’s strategy, objectives and plans for the next 12 to 24 months.